Introduction
Routine B.C.G. vaccination of children in the United Kingdom is recommended at 10-13 years of age and poliomyelitis and tetanus reinforcing immunization on leaving school at 15-19 years of age (Central Health Services Council, 1968) ; diphtheria immunization may be necessary also on leaving school. In practice, most children are turberculin tested and if necessary given B.C.G. vaccine in school, but few receive diphtheria, tetanus, or poliomyelitis vaccines at this time because of organizational difficulties. One way of overcoming these difficulties is to administer the vaccines at the same time. The purpose of this investigation was to measure the efficacy of B.C.G. vaccine, diphtheria-tetanus toxoid aluminium hydroxide adsorbed (P.T.A.H.), and live attenuated trivalent oral poliovaccine when given simultaneously to children aged 13-14 years. Rubella antibody titres were measured in sera remaining at the completion of the investigation.
Method
The investigation inicluded two trials in children who attended four secondary schools in Newham, London. In the first trial, which took place between December 1966 and March 1967, B.C.G. and diphtheria-tetanus vaccines were studied; in the second, between December 1968 and March 1969, these two vaccines together with oral poliovaccine were studied.
THE CHILDREN
Children whose parents consented to their participation in the investigation were Heaf tested with tuberculin purified protein derivative (P.P.D.) at a concentration equivalent to 100,000 units of old tuberculin per ml, prepared at the Central Veterinary Laboratory, Weybridge; those who were Heaf negative or Heaf positive grade 1, were divided into three immunization groups by using random sampling numbers.
In The immunizations and other procedures shown in Table I were carried out in school; children who were absent were visited at home and the appropriate procedures carried out there. At the end of the two trials the immunization of all the children against tuberculosis, diphtheria, tetanus, and poliomyelitis was completed. The B.C.G. vaccination lesion was inspected at about six weeks after vaccination, and a Mantoux test, using P;P.D. 10 TU/0 1 ml and read at 72 hours, was carried out at about 12 weeks after vaccination. Sera were collected from a random sample of children (Table I) ; three sera in the first trial-that is, before immunization and at 6 and 12 weeks after immunization-and paired-sera in the second trialbefore and six weeks after immunization.
The sera were titrated for diphtheria antitoxin in guineapigs by a method based on that described by Romer and Sames (1909) and for tetanus antitoxin in mice by the method described by Glenny and Stevens (1938) . The tests for neutralizing antibodies to the three types of poliovirus were carried out in primary monkey kidney cell tissue culture by a method based on that described by the World Health Organization (1958) . 30 
VACCINES
The vaccines were taken from stock for distribution in the United Kingdom: (1) freeze dried B.C.G. vaccine, 0-1 ml by intradermal injection; (2) diphtheria-tetanus toxoid aluminium hydroxide adsorbed containing 25 Lf of diphtheria toxoid and 5 Lf of tetanus toxoid, 0-5 ml by intramuscular injection; (3) tetanus toxoid aluminium hydroxide adsorbed containing 10 Lf of toxoid, 0 5 ml by intramuscular injection; (4) diphtheria antitoxin titres of less than 0.01 unit/ml (Table II) . The proportion of children with this low titre was higher in those with no record of previous immunization (32%) than in those who had a record of three or more injections (18%/,).
Though 170 (27%) of 628 children had no record, the parents of only 7 (1°,O) stated that their children had not been immunized. The antitoxin response to immunization in 189 children (Table III) suggests that about 3% had not been previously immunized-seven had antitoxin titres of less than 0-1 unit/ml six weeks after immunization and 6 (3%) of them had no record, the other child showed a delayed antitoxin response at 12 weeks of 0 5-1 unit/ml. The antitoxin response after immunization was similar in all immunization groups (Table III, Fig. 2 ) and was unaffected by the simultaneous administration of tetanus toxoid and B.C.G. and oral poliomyelitis vaccines. Paired sera of 33 children given only B.C.G. vaccine showed no significant variation in diphtheria antitoxin titre during the trials.
Thirty (8%) of -363 children given diphtheria-tetanus (P.T.A.H.) vaccine experienced pain and swelling at the in- when they were given "booster" diphtheria inoculation. The antitoxin response to immunization in 189 children (Table IV) suggests that about one-quarter in trial 1 and two-thirds in trial 2 had been previously immunized against tetanus-30 (280%) of 104 children in trial 1 had an antitoxin titre of 0 5 units/ml or more six weeks after immunization and 57 (67%) of 85 in trial 2.
The antitoxin response to immunization in each trial was similar in both immunization groups (Table IV, jection site which caused their absence from school for a day or more. All of the children had been previously immunized against diphtheria and only three against tetanus.
TETANUS IMMUNIZATION
Seventy-seven (740/0) of 104 children in trial 1 had tetanus antitoxin titres of less than 0-02 unit/ml before immunization and 54 (64 ') of 85 in trial 2 (Table IV) Number of Children Antitoxin Titre (Units/ml) Preimmunization sera were titrated between 0-02 and 5 units and the postimmunization sera between 0-1 and 5 units. Paired sera from 81 children in trial 2 were tested for antibody to the three types of virus; in a further four children there was insufficient serum for testing (Table I ). The response to vaccination was similar in both immunization groups (Table V, Fig. 4) . Many of the children had high initial antibody titres and it is not surprising, therefore, that not all of them increased after vaccination; most of the children had postvaccination antibody titres of 1/128 or more to all three types of virus. Two children had antibody titres of less than 1/8 to type 3 virus after vaccination-one had no record of past poliomyelitis immunization and the other had received three doses of oral poliovaccine six years previously. One child who had never been immunized had no antibody to type 1 virus after vaccination.
Of 12 children given only B.C.G. vaccine in the trial and from whom paired sera were obtained, two showed a fourfold rise in antibody to type 1 virus, two to type 2, and two to type 3. These children were close associates of the vaccinated children. There were no cases of neurological illness associated with vaccination either in the vaccinated children or their school contacts.
RUBELLA ANTIBODY Sera from 120 children (62 boys and 58 girls) in the first trial were tested for rubella antibody by the haemagglutinininhibition (H.A.I.) test by the method described by Stewart et al. (1967) . One hundred (83 x! ) of the 120 children had an H.A.I. antibody titre of 8 units or more; 50 (86'k'') girls and 50 (81') boys.
Discussion
The results recorded here show that the simultaneous administration of B.C.G., diphtheria-tetanus (P.T.A.H.), and oral poliomyelitis vaccines in children aged 13-14 years produces satisfactory responses to all these vaccines and does not affect their efficacy.
The proportion of children (22 ( ,) with preimmunization diphtheria antitoxin titres of less than 001 unit/ml is similar to our finding in 1963-4 in children aged 10-12 years (Galbraith et al., 1966) and again indicates the need for reinforcement of immunity. Diphtheria toxoid should be offered as soon as practicable to all children at about 13 years of age who have not been immunized since the age of 5 years.
Eight per cent. of children had moderately severe local reactions to diphtheria-tetanus (P.T.A.H) vaccine, which we consider makes it unacceptable for routine use in 13-year-old children. An "adult type" diphtheria-tetanus toxoid containing a low dose of diphtheria toxoid, and perhaps without adjuvant, might overcome the problem for this agc group. Within two to three years most 13-year-old children in the United Kingdom will have been immunized against both diphtheria and tetanus in infancy and reinforcement may then be possible with a small dose of fluid diphtheria-tetanus toxoid given by intramuscular or intradermal injection (Galbraith et al., 1966) . This study confirms the need for tetanus immunization in teenage children. The high proportion of children in trial 2 with low preimmunization antitoxin titres who responded rapidly to immunization at six weeks (Table IV) suggests that many of them had received inadequate primary immunization, probably a single injection of diphtheria-tetanus toxoid at the age of 5 years.
The polioantibody titres before immunization were similar to those previously reported (Galbraith and Fernandes, 1969) . Because 80/,, of children with a record of four or more doses of poliovaccine had antibody titres of less than 1/8 to type 1 virus, we suggest that the recommended reinforcing dose before leaving school should be given to all children irrespective of their previous immunization history.
We recommend, therefore, that all children at about the age of 13 years should be given tetanus toxoid aluminium hydroxide adsorbed vaccine and oral poliovaccine at the same time as B.C.G. vaccination in schools in areas where organizational difficulties otherwise prevent a high immunization rate at this age. Our experience indicates that such a combined immunization session in secondary schools would increase the acceptance rate for tetanus and poliomyelitis immunization in teenage children in the Borough of Newham from less than 5 % to over 80'%. We think that the advantages of this considerable increase in immunization rate outweigh the disadvantage of the theoretical possibility that simultaneous administration of these vaccines may result in live-vaccineinduced disease, a possibility which did not occur after the introduction of simultaneous administration of diphtheriatetanus-pertussis and oral poliomyelitis vaccines in infancy.
We have previously directed attention to the need for continued serological studies of polioantibody in children (Galbraith and Fernandes, 1969) , and this investigation shows that similar studies of diphtheria and tetanus antitoxins should become an essential part of the surveillance of community immunization programmes. Only by such studies can the future need for reinforcing doses of these vaccines be determined.
